Noboru Hattori Selected Research

Noboru Hattori Research Topics

Disease

40	Neoplasms (Cancer) 07/2022 - 04/2003
33	Lung Neoplasms (Lung Cancer) 07/2022 - 02/2007
28	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 07/2006
25	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2022 - 01/2003
16	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 11/2002
15	Adenocarcinoma of Lung 01/2022 - 06/2007
15	Fibrosis (Cirrhosis) 01/2021 - 11/2002
13	Pneumonia (Pneumonitis) 10/2022 - 05/2008
12	Chronic Obstructive Pulmonary Disease (COPD) 07/2021 - 12/2008
11	Asthma (Bronchial Asthma) 12/2022 - 01/2009
11	Idiopathic Pulmonary Fibrosis 01/2021 - 01/2003
9	Disease Progression 07/2022 - 11/2016
9	Lung Injury 01/2022 - 11/2002
9	Inflammation (Inflammations) 01/2021 - 12/2008
9	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2007
8	Adenoma (Adenomas) 01/2022 - 01/2018
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2021 - 10/2017
6	Adenocarcinoma 01/2019 - 05/2006
5	Carcinoma (Carcinomatosis) 10/2021 - 06/2011
5	Bronchiectasis 02/2021 - 01/2018
4	Adrenocortical Adenoma (Disease, Conn's) 01/2022 - 12/2018
4	Lewis Lung Carcinoma 09/2018 - 02/2007
3	Rheumatoid Arthritis 10/2022 - 09/2009
3	Acute Lung Injury 01/2022 - 01/2020
3	Radiation Pneumonitis 12/2021 - 03/2012
3	Glucose Intolerance 11/2021 - 01/2013
3	Emphysema 04/2021 - 01/2016
3	Organizing Pneumonia 11/2020 - 01/2009
3	Idiopathic Interstitial Pneumonias 04/2020 - 01/2003
3	Breast Neoplasms (Breast Cancer) 01/2019 - 05/2006
3	Hemorrhage 12/2018 - 12/2012
3	Infections 12/2018 - 07/2017
3	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 12/2017 - 11/2016
2	Pulmonary Alveolar Proteinosis 02/2022 - 03/2012
2	Respiratory Insufficiency (Respiratory Failure) 02/2022 - 01/2017
2	Dyspnea (Shortness of Breath) 01/2022 - 02/2021
2	Cushing Syndrome 12/2021 - 12/2018
2	Carcinogenesis 10/2021 - 10/2020

Drug/Important Bio-Agent (IBA)

20	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2011
14	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 11/2002
11	Plasminogen Activator Inhibitor 1IBA 01/2019 - 11/2002
11	Plasminogen Activators (Plasminogen Activator)IBA 01/2019 - 11/2002
10	Immune Checkpoint InhibitorsIBA 02/2022 - 12/2018
10	Pharmaceutical PreparationsIBA 02/2021 - 01/2009
9	LigandsIBA 07/2022 - 02/2011
9	ErbB Receptors (EGF Receptor)IBA 01/2022 - 06/2008
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2003
7	AldosteroneIBA 01/2022 - 01/2018
7	CytokinesIBA 01/2021 - 05/2008
6	EnzymesIBA 01/2022 - 01/2012
6	pembrolizumabIBA 01/2022 - 03/2019
6	Tyrosine Kinase InhibitorsIBA 09/2021 - 06/2008
6	AntigensIBA 04/2021 - 05/2006
6	Mucin-1 (CA 15-3 Antigen)IBA 01/2019 - 12/2005
5	Prednisolone (Predate)FDA LinkGeneric 12/2022 - 01/2018
5	Anti-Bacterial Agents (Antibiotics)IBA 07/2022 - 07/2017
5	osimertinibIBA 01/2022 - 01/2019
5	Carboplatin (JM8)FDA LinkGeneric 11/2021 - 10/2011
5	Cisplatin (Platino)FDA LinkGeneric 02/2021 - 01/2016
5	Small Interfering RNA (siRNA)IBA 01/2021 - 04/2010
5	AntibodiesIBA 12/2019 - 06/2007
5	CollagenIBA 12/2017 - 02/2007
5	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2016 - 10/2007
4	Immunoglobulin G (IgG)IBA 12/2022 - 01/2012
4	NivolumabIBA 02/2021 - 01/2018
4	Interleukin-6 (Interleukin 6)IBA 01/2021 - 04/2009
4	Messenger RNA (mRNA)IBA 01/2021 - 01/2018
4	ImmunosorbentsIBA 12/2019 - 01/2012
4	Bevacizumab (Avastin)FDA Link 12/2018 - 01/2017
4	CD13 Antigens (Alanine Aminopeptidase)IBA 01/2018 - 04/2003
4	Peptides (Polypeptides)IBA 11/2017 - 01/2015
4	Monoclonal AntibodiesIBA 07/2015 - 05/2006
4	PlasminogenIBA 10/2012 - 11/2002
3	SteroidsIBA 12/2022 - 01/2018
3	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 12/2018
3	mepolizumabIBA 01/2022 - 07/2021
3	Receptor for Advanced Glycation End ProductsIBA 01/2022 - 01/2017
3	HMGB1 Protein (HMG1)IBA 12/2021 - 01/2020
3	Etoposide (VP 16)FDA LinkGeneric 11/2021 - 01/2018
3	B7-H1 AntigenIBA 10/2021 - 08/2019
3	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2021 - 12/2008
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 10/2011
3	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2019 - 03/2018
3	suplatast tosilateIBA 01/2019 - 01/2009
3	Docetaxel (Taxotere)FDA Link 12/2018 - 01/2011
3	Sirolimus (Rapamycin)FDA Link 12/2017 - 11/2016
3	Glycoproteins (Glycoprotein)IBA 12/2017 - 06/2007
3	SK-216IBA 01/2016 - 11/2013
2	Interleukin-13IBA 12/2022 - 01/2016
2	Methotrexate (Mexate)FDA LinkGeneric 10/2022 - 09/2009
2	Trimethoprim (Proloprim)FDA LinkGeneric 07/2022 - 01/2021
2	Sulfamethoxazole FDA LinkGeneric 07/2022 - 01/2021
2	atezolizumabIBA 11/2021 - 01/2021

Therapy/Procedure

26	Therapeutics 07/2022 - 04/2003
22	Drug Therapy (Chemotherapy) 07/2022 - 01/2011
6	Radiotherapy 12/2021 - 06/2017
5	Chemoradiotherapy 12/2021 - 10/2017
5	Traction 02/2021 - 01/2018
4	Aftercare (After-Treatment) 06/2020 - 04/2003
2	Oral Administration 10/2022 - 06/2017